Insights Center
Thought leadership, news, events — you will find them all here, right at your fingertips. We’ve consolidated the firm’s most popular content in one, easy to search location. Enter a key word or phrase to find pertinent blog posts, articles, press releases, and upcoming events.
Mintz Direct
Mintz Viewpoints
Showing 9913 - 9920 of 12011 results
Privacy Monday: December 8, 2104 - The Twelve Days of Privacy 2014
December 8, 2014| Blog| Viewpoint
After the Deal, is it Still Business as Usual?
December 8, 2014| Blog| Viewpoint
Federal Judge Awards Attorneys’ Fees to Defendant in Dismissed Qui Tam Case, Calls Whistleblower a “Serial Relator”
December 5, 2014| Blog| Viewpoint
Medtronic and Covidien’s Blockbuster Medical Products Merger Clears FTC Antitrust Review with Divestiture
December 5, 2014| Advisory| Viewpoint
SBIR/STTR Policy Directive Update: What’s Ahead for Data Rights
December 5, 2014| Advisory| Viewpoint
CPSC to Discuss Draft Phthalates Rule at December 5th Meeting
December 4, 2014| Blog| Viewpoint
Update: New York Employers Will Still Be Required to Distribute Annual Pay Notices in January 2015
December 4, 2014| Blog| Viewpoint
Issuer Banks’ Claims in Target Data Breach Litigation Survive Motion to Dismiss
December 4, 2014| Blog| Viewpoint
News & Press Releases
Mintz advised The Eagle Leasing Company, a leading provider of portable storage containers, ground level offices, semi-trailers, and mobile office solutions, in its acquisition by Rent-A-Container (RAC), a portfolio company of Kinderhook Industries, LLC.
Mintz’s Life Sciences practice has been shortlisted in multiple categories for the 2025 LMG Life Sciences Americas Awards. The winners will be announced at an awards ceremony in New York on September 4. In the United States, Mintz was shortlisted in the “Venture Capital Firm of the Year” category. In Canada, Mintz was shortlisted in the “Financial & Corporate Firm of the Year” and “Patent Strategy Firm of the Year” categories.
Mintz advised ArriVent BioPharma, Inc., a clinical-stage biopharmaceutical company dedicated to the identification, development, and commercialization of differentiated medicines to address the unmet medical needs of patients with cancers, on a $75 million underwritten public offering of 2,482,692 shares of its common stock and pre-funded warrants to purchase up to 1,363,469 shares of its common stock. The common stock is listed on The Nasdaq Global Market under the symbol “AVBP.“
Events
Mintz x The Engine: Supercharging Your IP Strategy with Trade Secrets
The Engine, 750 Main St. Cambridge, MA 02139
Podcasts
Health Law Diagnosed – Best Practices for Communicating with the FDA
July 9, 2025| Podcast|
Mintz On Air: Practical Policies – An Abridged Guide to Crisis Management
July 1, 2025| Podcast|